Literature DB >> 18047918

Determinants of reduction of coronary flow reserve in patients with type 2 diabetes mellitus or arterial hypertension without angiographically determined epicardial coronary stenosis.

Maurizio Galderisi1, Brunella Capaldo, Milena Sidiropulos, Arcangelo D'Errico, Luigi Ferrara, Annamelia Turco, Pasquale Guarini, Gabriele Riccardi, Oreste de Divitiis.   

Abstract

BACKGROUND: Coronary flow reserve (CFR) may be reduced even in the absence of coronary artery disease. We investigated the determinants of CFR impairment in Type 2 diabetes mellitus (DM2) and in arterial hypertension (HTN) without epicardial coronary artery stenosis.
METHODS: Twenty-eight patients with DM2 and 27 with HTN, both with normal coronary angiography, and 18 healthy controls underwent transthoracic echocardiography, including Doppler recording of the distal left anterior descending artery, at rest as well as after high-dose dipyridamole. Coronary flow reserve was calculated as the hyperemic to resting coronary diastolic peak velocities ratio.
RESULTS: The three groups were comparable for sex, age, and heart rate. Systolic and mean blood pressures were higher in DM2 and HTN patients than in control subjects. Diabetic and hypertensive patients had a higher left-ventricular mass index (LVMi) and relative wall thickness, impaired diastolic indexes, and lower CFR compared with control subjects (P = .02 and P = .03, respectively) because of lower hyperemic coronary velocity (P = .005 and P = .004, respectively). After a multilinear regression analysis (using age, sex, HTN status, DM2 status, smoking, total cholesterol/HDL-cholesterol ratio, and LVMi as potential determinants), the LVMi increase was the main predictor of the reduction of CFR, adjusted for mean BP (P < .0001), in the pooled population, with a minor contribution of age (P = .03), HTN status (P = .02), and DM2 status (P = .03).
CONCLUSIONS: In Type 2 DM and HTN without epicardial coronary stenosis, an impairment of CFR is demonstrable. This is partly explained by an increased left-ventricular mass, able to condition the hyperemic stimulation of myocardial blood flow.

Entities:  

Mesh:

Year:  2007        PMID: 18047918     DOI: 10.1016/j.amjhyper.2007.08.005

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  11 in total

1.  Upregulation of eNOS and unchanged energy metabolism in increased susceptibility of the aging type 2 diabetic GK rat heart to ischemic injury.

Authors:  Martine Desrois; Kieran Clarke; Carole Lan; Christiane Dalmasso; Mark Cole; Bernard Portha; Patrick J Cozzone; Monique Bernard
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-08-20       Impact factor: 4.733

2.  Association of arterial stiffness with coronary flow reserve in revascularized coronary artery disease patients.

Authors:  Vlassis Tritakis; Stavros Tzortzis; Ignatios Ikonomidis; Kleanthi Dima; Georgios Pavlidis; Paraskevi Trivilou; Ioannis Paraskevaidis; Giorgos Katsimaglis; John Parissis; John Lekakis
Journal:  World J Cardiol       Date:  2016-02-26

3.  Effects of type 2 diabetes mellitus on coronary microvascular function and myocardial perfusion in patients without obstructive coronary artery disease.

Authors:  Caterina Marciano; Maurizio Galderisi; Paola Gargiulo; Wanda Acampa; Carmen D'Amore; Roberta Esposito; Enza Capasso; Gianluigi Savarese; Laura Casaretti; Francesco Lo Iudice; Giovanni Esposito; Giuseppe Rengo; Dario Leosco; Alberto Cuocolo; Pasquale Perrone-Filardi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-04-12       Impact factor: 9.236

4.  Response to pulmonary arterial hypertension drug therapies in patients with pulmonary arterial hypertension and cardiovascular risk factors.

Authors:  Athanasios Charalampopoulos; Luke S Howard; Ioanna Tzoulaki; Wendy Gin-Sing; Julia Grapsa; Martin R Wilkins; Rachel J Davies; Petros Nihoyannopoulos; Susan B Connolly; J Simon R Gibbs
Journal:  Pulm Circ       Date:  2014-12       Impact factor: 3.017

5.  Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes.

Authors:  Cecilia Marini; GianPaolo Bezante; Patrizia Gandolfo; Elisa Modonesi; Silvia D Morbelli; Angelo Depascale; Daniela Rollando; Davide Maggi; Manuela Albertelli; Riccardo Armonino; Manrico Balbi; Claudio Brunelli; Renzo Cordera; Gianmario Sambuceti
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-03       Impact factor: 9.236

6.  Coronary flow reserve after L-thyroxine therapy in Hashimoto's thyroiditis patients with subclinical and overt hypothyroidism.

Authors:  Huseyin Oflaz; Ramazan Kurt; Fatma Sen; Imran Onur; Arif Oguzhan Cimen; Ali Elitok; Kultigin Turkmen; Burak Pamukcu; Erdem Kasikcioglu; Zehra Bugra; Fehmi Mercanoglu; Nese Ozbey
Journal:  Endocrine       Date:  2008-01-26       Impact factor: 3.633

7.  Inadequate Blood Pressure Control in Hypertensive Patients Referred for Cardiac Stress Test.

Authors:  Tarek M Mousa; Oluwaseun A Akinseye; Todd C Kerwin
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-05-23       Impact factor: 3.738

8.  Association Between Elevated Pulse Pressure and High Resting Coronary Blood Flow Velocity in Patients With Angiographically Normal Epicardial Coronary Arteries.

Authors:  Maria Lembo; Rosa Sicari; Roberta Esposito; Fausto Rigo; Lauro Cortigiani; Francesco Lo Iudice; Eugenio Picano; Bruno Trimarco; Maurizio Galderisi
Journal:  J Am Heart Assoc       Date:  2017-06-29       Impact factor: 5.501

9.  Relationship Between Brachial Artery Flow-Mediated Dilation, Carotid Artery Intima-Media Thickness and Coronary Flow Reserve in Patients With Coronary Artery Disease.

Authors:  Fahrettin Oz; Ali Elitok; Ahmet Kaya Bilge; Fehmi Mercanoglu; Huseyin Oflaz
Journal:  Cardiol Res       Date:  2012-09-20

10.  The impact of aging and atherosclerotic risk factors on transthoracic coronary flow reserve in subjects with normal coronary angiography.

Authors:  Maurizio Galderisi; Fausto Rigo; Sonia Gherardi; Lauro Cortigiani; Ciro Santoro; Rosa Sicari; Eugenio Picano
Journal:  Cardiovasc Ultrasound       Date:  2012-05-14       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.